Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Other · 2016 Article · 18 Mar 2026 Antipsychotics vs. ECT with Antipsychotics: A PANSS and SCORS Investigation in Paranoid Schizophrenia
subtype, presents significant impairments in perception, thinking, language, memory, attention, and decision-making. Atypical antipsychotics has been considered as the mainline treatment approach. Electroconvulsive…
Short communication · Apr 2020 Psychiatry 2020 : Effectiveness Oral Antipsychotic Versus Long-Acting-Injectable Antipsychotics: a Comparison of Suicidality, Relapse, and Recidivism
Long acting injectable antipsychotic (LAI) medication has been shown extensively to reduce relapse rates in schizophrenic patients previously treated with oral antipsychotics (OA). This study seeks to determine whether…
Conference abstract · 21 Jun 2019 Are we really helping our patients with Antidepressants and Antipsychotics for GAD, Panic and PTSD Disorder: Benzodiazepines vs Antidepressants for Anxiety Disorders
most spectacular achievements of propaganda in psychiatry. The use of antipsychotics for anxiety disorders follows the same lines.” I argue that Benzodiazepines should be considered first-line pharmacological treatment
Conference abstract · 25 Apr 2019 Concurrent antipsychotic use in older adults treated with antidepressants in Asia
people up to 7-18 times more frequently than for middle-aged adults. Antipsychotics (APs) are often used as an adjunctive treatment with antidepressants (ADs) in this population
Conference abstract · 21 May 2018 Outcomes in patients with first episode Schizophrenia treated with long-acting antipsychotic injections
Objectives: To compare the clinical efficacy of the long-acting injectable antipsychotics with the oral antipsychotics in the first episode of schizophrenia. Background: Noncompliance is a major problem for patients…
Research article · 6 Nov 2017 Lack of Pharmacokinetic Interaction between Antipsychotics (Quetiapine, Clozapine and Olanzapine) and the Beta-Blockers Metoprolol, Propranolol, Bisoprolol and Nebivolol Except between Carvedilol and the Antipsychotics Quetiapine and Clozapine
purpose of this study was to evaluate a potential pharmacokinetic interaction between antipsychotics (quetiapine QUE, clozapine CLO and olanzapine OLA) and beta-blockers (metoprolol MET, propranolol PRO, bisoprolol BIS…
Research article · 4 Nov 2017 Effectiveness of Oral Antipsychotic versus Long-Acting-Injectable Antipsychotics: A Comparison of Suicidality, Relapse, and Recidivism
Background: Long acting injectable antipsychotic (LAI) medication has been shown extensively to reduce relapse rates in schizophrenic patients previously treated with oral antipsychotics (OA). This study seeks to…
Conference abstract · 2017 Music and memory in memory care units resulted in reduction of unnecessary usage of antipsychotics, falls and physical altercations
Improve Dementia Care, established a new national goal of reducing the use of antipsychotic medications in long-stay nursing home residents by providing person centered Comprehensive interdisciplinary care. Implement…
Conference abstract · 3 Oct 2016 Understanding the impact of antipsychotic medication and associated side effects on peoples’ lives
Antipsychotic medication plays an important role in the treatment of people experiencing severe mental health problems. However, antipsychotic medication often produces troubling side effects. Severe side effects…
Review article · 25 May 2016 Comparison of long-acting antipsychotic injection and oral antipsychotics in schizophrenia
this article is to highlight objective differences between antipsychotic (both first generation and second generation) long-acting injections (LAIs) and typical and atypical oral antipsychotics, in terms of clinical…
Conference abstract · 2 May 2016 Current cognizance about the clinical features, course and treatment by antipsychotics which acts as a “double edged sword” in a research case of very early onset schizophrenia
prevalence of obsessive-compulsive symptoms (OCS) in patients with schizophrenia is relatively high. Antipsychotics have been found to influence OCS. Aim & Objective: The present paper reviews the current knowledge with
Conference abstract · 27 Jul 2015 Prevalence, gender differences, and risk factors of metabolic syndrome in Han-Chinese with schizophrenia taking second-generation antipsychotics in Taiwan
differences, and risk factors for metabolic syndrome of patients with schizophrenia using second-generation antipsychotics. A cross-sectional sample of 329 patients was recruited in central Taiwan. Prevalence was…
Article · 2015 The Ideal Antipsychotic: Hybrid between Typical andldquo;Haloperidolandrdquo; And the Atypical andldquo;Clozapineandrdquo; Antipsychotic
differences in types of psychoses, the suboptimal therapeutic response of psychotic individuals to antipsychotics, the variation of the therapeutic effects of the same antipsychotic on different individuals with the…
Article · 29 Dec 2025 Evaluating Bioequivalence in Antipsychotic Medications for Consistent Patient Care
Opinion · 29 Nov 2025 Antipsychotics: Outcomes, Side Effects, Future Innovations
Perspective · 31 Oct 2025 Antipsychotic Medications: Efficacy, Tolerability, And Choice
Ibrahim Suleiman* HTML PDF Share this article
Article · 30 Oct 2025 Bioequivalence Assessment of Antipsychotic Drugs in Modern Psychiatric Practice
Article · 30 Oct 2025 Evaluating Bioequivalence in Antipsychotic Medications and Its Clinical Relevance

